<DOC>
	<DOCNO>NCT00913250</DOCNO>
	<brief_summary>Demonstrate bioequivalence serum-free solution serum contain solution Avonex .</brief_summary>
	<brief_title>A Bioequivalence Study Serum Free Avonex Serum Containing Avonex Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1a</mesh_term>
	<criteria>Healthy Volunteers History severe allergic anaphylactic reaction History hypersensitivity acetaminophen ( paracetamol ) , ibuprofen , codeine . Known allergy dry natural rubber History seizure disorder unexplained blackout History clinically significant ( determined Investigator ) cardiac , endocrinologic , hematologic , hepatic , immunologic , metabolic , urologic , pulmonary , neurologic , dermatologic , psychiatric , renal , and/or major disease Other inclusion exclusion criterion apply per protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Interferon beta-1a</keyword>
</DOC>